ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
46
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
5,212
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Orphan drugs and the NHS: should we value rarity?
Author(s):
Christopher McCabe
,
Aki Tsuchiya
,
Karl Claxton
Publication date:
2005-10-29
Journal:
BMJ : British Medical Journal
Keywords:
Cost-Benefit Analysis
,
Drug Costs
,
Health Status
,
Humans
,
Orphan Drug Production
,
economics
,
Rare Diseases
,
drug therapy
,
State Medicine
,
Treatment Outcome
Read this article at
ScienceOpen
Publisher
PMC
Further versions
oa repository (via OAI-PMH doi match)
oa repository (via pmcid lookup)
oa repository (via OAI-PMH doi match)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Annual Reviews Top Downloaded Articles in 2020
Author and article information
Journal
PubMed ID::
16254305
PMC ID::
1273462
DOI::
10.1136/bmj.331.7523.1016
ScienceOpen disciplines:
Chemistry
Keywords:
Cost-Benefit Analysis
,
Drug Costs
,
Health Status
,
Humans
,
Orphan Drug Production
,
economics
,
Rare Diseases
,
drug therapy
,
State Medicine
,
Treatment Outcome
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Cost-Benefit Analysis
,
Drug Costs
,
Health Status
,
Humans
,
Orphan Drug Production
,
economics
,
Rare Diseases
,
drug therapy
,
State Medicine
,
Treatment Outcome
Comments
Comment on this article
Sign in to comment
scite_
Similar content
5,212
Dynamic patterned expression of orphan nuclear receptor genes RORalpha and RORbeta in developing mouse forebrain.
Authors:
Yasushi Nakagawa
,
Dennis D M O'Leary
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
Authors:
Anne EM Brabers
,
Ellen HM Moors
,
Sonja van Weely
…
Orphan Crops Browser: a bridge between model and orphan crops
Authors:
Claire Alvim Kamei
,
Edouard I. Severing
,
Annemarie Dechesne
…
See all similar
Cited by
45
Essential medicines for universal health coverage
Authors:
Veronika Wirtz
,
Hans V Hogerzeil
,
Andrew L Gray
…
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
Authors:
David Moore
,
Martin J Connock
,
Ed Wraith
…
Pricing and reimbursement of orphan drugs: the need for more transparency
Authors:
Steven Simoens
See all cited by